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Abstract
Objective. Many consider smoking to be a personal choice for which individuals should be held accountable. We assessed
whether there is any evidence of bias against smokers in cardiac care decision-making by determining whether smokers were as
likely as non-smokers to undergo revascularization procedures after cardiac catheterization.
Design. Prospective cohort study.
Subjects and setting. All patients undergoing cardiac catheterization in Alberta, Canada.
Main measures. Patients were categorized as current smokers, former smokers, or never smokers, and then compared for their
risk-adjusted likelihood of undergoing revascularization procedures (percutaneous coronary intervention or coronary artery
bypass grafting) after cardiac catheterization.
Results. Among 20406 patients undergoing catheterization, 25.4% were current smokers at the time of catheterization, 36.6%
were former smokers, and 38.0% had never smoked. When compared with never smokers (reference group), the hazard ratio
for undergoing any revascularization procedure after catheterization was 0.98 (95% CI 0.93–1.03) for current smokers and 0.98
(0.94–1.03) for former smokers. The hazard ratio for undergoing coronary artery bypass grafting was 1.09 (1.00–1.19) for
current smokers and 1.00 (0.93–1.08) for former smokers. For percutaneous coronary intervention, the hazard ratios were 0.93
(0.87–0.99) for current smokers and 1.00 (0.94–1.06) for former smokers.
Conclusion. Despite potential for discrimination on the basis of smoking status, current and former smokers undergoing
cardiac catheterization in Alberta, Canada were as likely to undergo revascularization procedures as catheterization patients
who had never smoked.
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Socioeconomic and racial disparities in health care quality
have been extensively documented [1–3], and recently, the
elimination of disparities in health care has become the objec-
tive of several initiatives [4]. While many studies have focused
on disparities by sex, race, ethnicity, or socioeconomic status,
it has also been suggested that smokers may be a subset of the
population who are vulnerable to social stigmatization and
unfavorable stereotypes [5]. Smoking cigarettes is viewed by
some health professionals as a personal lifestyle choice, and as
a result, smokers might be judged by some to be responsible
for the health consequences of their behavior [6]. Such a stig-
matizing approach toward patients who smoke might incite
health care providers to be less enthusiastic about offering
invasive and expensive procedures, such as percutaneous
coronary intervention or coronary artery bypass grafting.
Given the limited financial resources in many health care sys-
tems, some have questioned the rationale for offering all
available (particularly expensive) medical procedures to indi-
viduals with sub-optimal ‘health conscious’ profiles. Specifi-
cally, some have asked whether smokers should be given the
same opportunity for coronary artery bypass grafting as non-
smokers [6].
To our knowledge, there are no data on the role of smoking
as a predictor of unequal access to care. In this study, we used
a large and clinically detailed regional registry of patients
undergoing cardiac catheterization to assess whether smokers
were as likely as non-smokers to undergo coronary revascu-
larization procedures after cardiac catheterization.
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Methods
Data source and variables
The data source for the present study was from APPROACH,
the Alberta Provincial Project for Outcome Assessment in
Coronary Heart disease, a study that has previously been
described in detail [7]. Briefly, APPROACH is an ongoing
prospective cohort study of all patients who undergo cardiac
catheterization in the Canadian Province of Alberta. Patients
are observed longitudinally for assessment of long-term out-
comes such as death and subsequent revascularization. At the
time of cardiac catheterization, data are collected on age, sex,
cerebrovascular disease, heart failure, chronic pulmonary dis-
ease, serum creatinine level, renal dialysis, hyperlipidemia,
hypertension, liver or gastrointestinal disease, malignancy or
metastatic disease, prior coronary artery bypass grafting, prior
percutaneous coronary intervention, prior myocardial infarc-
tion, prior thrombolytic therapy for myocardial infarction,
and peripheral vascular disease. The indication for catheter-
ization is recorded in APPROACH as myocardial infarction,
unstable angina, stable angina, or other. The results of cardiac
catheterization, including coronary anatomy and left ventricu-
lar ejection fraction, are recorded when available (quantitative
ejection fraction assessments are not always performed depend-
ing on individual patients’ clinical status). In describing coro-
nary anatomy, a vessel is considered to be diseased when it
contains a lesion with ≥50% stenosis, and extent of disease is
categorized into six groups; normal, 1–2 vessel disease, 2 vessel
disease with involvement of the proximal left anterior descend-
ing artery, 3 vessel disease, 3 vessel disease with involvement
of the proximal left anterior descending artery, and left main
disease.
Smoking is defined as smoking at least one cigarette a day
and this variable is considered to be present if mentioned in a
patient’s hospital record or reported by the patient at the time
of catheterization. The other clinical variables listed above, such
as diabetes, are similarly considered to be present if mentioned
in a patient’s hospital records or reported by the patient when
questioned at the time of catheterization. The subsequent
occurrence of coronary artery bypass grafting or percutaneous
coronary intervention after cardiac catheterization is also
captured in the APPROACH database.
Analysis
Patients’ smoking status was defined in three categories: current
smokers (i.e. smoking at the time of index catheterization),
former smokers, and never smokers. We then proceeded to
compare the clinical characteristics of these three patient groups
using chi-squared tests or analysis of variance, as appropriate.
The unadjusted occurrence of coronary revascularization
procedures during the 12 months after the index catheterization
was compared between the three smoking groups through the
log-rank test, and time-to-event curves were calculated and
plotted using the cumulative incidence competing risks
method [8,9] for the endpoints of (i) coronary artery bypass
grafting, (ii) percutaneous coronary intervention, and (iii) any
revascularization after catheterization. The time frame of
12 months after catheterization was selected for study
because this represents a time interval within which most
planned revascularization procedures after catheterization
would have occurred. Interventions occurring beyond 12
months are likely to be indicative of new clinical events.
After ensuring appropriateness of the proportional hazards
assumption, we then used proportional hazards models to
determine the adjusted likelihood of undergoing revasculari-
zation procedures for each of the three smoking status
groups, while controlling for other factors that might influence
the likelihood of revascularization. These factors were age, sex,
co-morbidities (e.g. diabetes, renal disease), previous invasive
cardiac procedures, thrombolytic therapy, indication for cath-
eterization (recent myocardial infarction, unstable angina, stable
angina, other), left ventricular ejection fraction, and extent of
coronary artery disease.
All analyses were conducted by one of the study authors
(P.D.F.) using S-Plus, Version 5, for Linux (Insightful Corpo-
ration, Seattle, WA, USA, 1999). The APPROACH initiative
has been reviewed and approved by the ethics review com-
mittees of the University of Calgary, Calgary, Alberta, and the
University of Alberta, Edmonton, Alberta.
Results
From January 1995 to December 1997, 20 406 patients under-
went cardiac catheterization in Alberta. Their mean age was
62.5 years and 32% were female. Twenty-five percent of these
patients were current smokers, 36.6% were former smokers,
and the remaining 38% had never smoked. Baseline patient
characteristics (Table 1) show that current smokers were
younger, more likely to be male and to have had previous
myocardial infarction and thrombolytic therapy than never
smokers. The distribution of the clinical indication for cathe-
terization showed that smokers were more likely to undergo
cardiac catheterization with an indication of ‘myocardial infarc-
tion’ than were non-smokers. Correspondingly, smokers were
less likely to have stable angina as the indication for their
procedures.
Figure 1 presents time-to-event curves for the endpoints of
any revascularization procedure (Figure 1A), percutaneous
coronary intervention (Figure 1B), and coronary artery bypass
grafting (Figure 1C) in the 12 months after the index cardiac
catheterization. The plots suggest that smokers (current or
former) are more likely to undergo revascularization proce-
dures than are never smokers (P < 0.001 for all three analyses).
However, because the demographic and clinical characteris-
tics differed across the three groups, a multivariable propor-
tional hazards analysis was performed. This analysis indicated
that smoking status was not an independent predictor of the
probability that a patient would undergo revascularization
procedures (Table 2). When compared with never smokers
(reference group), the hazard ratio for undergoing any revas-
cularization procedure (percutaneous coronary intervention
or coronary artery bypass grafting) after catheterization was
0.98 (95% CI 0.93–1.03) for current smokers and 0.98
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(0.94–1.03) for former smokers. The hazard ratio for undergo-
ing coronary artery bypass grafting was 1.09 (1.00–1.19) for
current smokers and 1.00 (0.93–1.08) for former smokers.
For percutaneous coronary intervention, the corresponding
hazard ratios were 0.93 (0.87–0.99) for current smokers and
1.00 (0.94–1.06) for former smokers (Table 2).
We also performed selected subgroup analyses to deter-
mine whether there were specific patient subgroups in whom
smoking status might play a more important role. Specifi-
cally, we formally assessed whether age (<65 versus ≥65),
sex, congestive heart failure, or diabetes modified our findings,
and also tested the statistical significance of two-way inter-
action terms between these variables and smoking. These
supplementary analyses revealed no statistically significant
interaction terms, and for the most notable endpoint of any
revascularization procedure, none of the smoking hazard
Table 1 Patient characteristics
1P value based on analysis of variance for age comparisons, and on chi-squared tests for all other comparisons.
2Abbreviations: CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; PLAD indicates disease involving the
proximal left anterior descending artery.
Variable
......................................................................................................................................
Smoking category
Never Previous Current P-value1
N = 7752 N = 7472 N = 5182
(38.0%) (36.6%) (25.4%)
.........................................................................................................................................................................................................................
Mean age (years) 64.7 64.3 56.4 <0.001
Sex (% female) 40.1 20.2 26.9 <0.001
Peripheral vascular disease (%) 5.1 8.6 8.8 <0.001
Chronic lung disease (%) 6.9 10.3 11.2 <0.001
Cerebrovascular disease (%) 5.9 6.4 5.2 0.021
Creatinine > 200 mmol/litre (%) 3.0 2.1 1.9 <0.001
Congestive heart failure (%) 14.5 15.0 13.2 0.019
Dialysis (%) 1.6 1.2 1.0 0.019
Diabetes (%) 20.0 18.8 15.9 <0.001
Hypertension (%) 54.6 54.0 46.7 <0.001
Hyperlipidemia (%) 39.3 45.7 46.2 <0.001
Liver disease (%) 2.8 3.6 3.8 0.004
Malignancy (%) 3.2 3.9 2.7 <0.001
Previous myocardial infarction (%) 45.4 50.9 58.1 <0.001
Previous CABG2 (%) 7.5 10.0 4.4 <0.001
Previous PCI2 (%) 11.0 13.3 8.8 <0.001
Prior thrombolytic therapy (%) 9.4 10.7 17.3 <0.001
Indication for catheterization (%) <0.001
Myocardial infarction 23.5 21.9 37.3
Stable angina 32.0 35.0 25.1
Unstable angina 30.5 31.3 28.2
Other 14.0 11.8 9.4
Extent of coronary disease (%) <0.001
Normal or near normal 24.3 16.4 17.5
1–2 vessel disease 20.4 22.6 29.1
2 vessel disease + PLAD2 14.5 15.1 16.7
3 vessel disease 18.6 20.9 18.7
3 vessel disease + PLAD2 14.1 15.4 11.8
Left main disease 8.0 9.5 6.3
Ejection fraction (%) <0.001
<30 4.3 5.6 5.6
30–50 19.7 21.9 23.1
>50 57.6 57.0 55.8
Ventriculogram not done 4.8 3.8 3.9
Missing 13.6 11.6 11.6
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ratios differed significantly from 1.0. Hazard ratios for these
subgroup analyses (for smokers relative to non-smokers)
ranged from a low of 0.93 (0.82–1.07) to a high of 1.03
(0.94–1.13).
Discussion
By focusing on events after cardiac catheterization, our study
assesses the latter portion of the coronary revascularization
care sequence. This is a period during which interventional
cardiologists and cardiac surgeons are asked to accept patients
for revascularization procedures—a decision-making process
that smoking status may influence. Despite this possibility,
however, our findings indicate that smokers are not less likely
than non-smokers to undergo coronary revascularization in
the year following cardiac catheterization.
Underwood and Bailey [6] have argued that, in the context
of limited resources, offering smokers cardiac surgery ‘deprives
patients who have never smoked or have stopped smoking of
more efficient and effective surgery’. They defend this argu-
ment by pointing out that patients who smoke may spend
longer in hospital and have poor results from surgery. In
concluding their commentary, these authors boldly declare
that ‘subjecting patients who continue to smoke and for
whom the only indication for operation is the relief of
angina, to the increased risks of surgery in the face of a reme-
diable cause is not justified’. Of relevance, these comments
shortly predated the years we assessed in this study using
APPROACH data.
Others argue against this position on both financial and
ethical grounds. In particular, Shiu [10] has illustrated the
dangers of discriminating against smokers by pointing out
that we could similarly deny care to drunken victims of traffic
accidents, suicide survivors, asthmatic smokers, and others.
Our findings suggest that cardiac care providers in the region
studied have not widely adopted the view of Underwood and
Bailey.
While equally likely to undergo any revascularization rela-
tive to patients who have never smoked, current smokers
were somewhat less likely to undergo percutaneous coronary
Figure 1 Time-to-event curves by smoking status group for
the endpoints of any revascularization procedure (Panel A),
percutaneous coronary intervention (PCI; Panel B), and
coronary artery bypass grafting (CABG; Panel C) in the
12 months after cardiac catheterization.
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Table 2 Adjusted hazard ratios1 indicating likelihood of
revascularization
1Hazard ratios are adjusted for all of the clinical factors listed in
Table 1.
2Abbreviations: CABG, coronary artery bypass grafting; PCI, percu-
taneous coronary intervention.
Type of 
revascularization
Hazard ratio 95% Confidence
intervals
.......................................... .................................................................
Current smokers versus
never smokers
Any type 0.98 0.93–1.03
CABG2 1.09 1.00–1.19
PCI2 0.93 0.87–0.99
Former smokers versus 
never smokers
Any type 0.98 0.94–1.03
CABG2 1.00 0.93–1.08
PCI2 1.00 0.94–1.06
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intervention. This was countered by a slightly greater likeli-
hood of undergoing coronary artery bypass grafting. While
this finding raises the possibility of differing attitudes towards
smokers among interventional cardiologists compared with
cardiac surgeons, the fact that the most important endpoint
of any revascularization procedure was equivalent between
groups indicates globally similar access to cardiac care regard-
less of smoking status.
This report has several strengths. Firstly, our database con-
tains relevant clinical information on a wide variety of clinical
variables that can affect the likelihood of cardiac procedures,
such as extent of coronary disease, left ventricular ejection
fraction, co-morbidities, and previous cardiovascular proce-
dures [11]. This database provided the opportunity to study
the relationship between smoking status and revascularization
procedures while controlling for these other important fac-
tors. Secondly, data come from an unselected population
within a defined geographic area and from a health care sys-
tem with a single payer and equal access. This limits the
impact of provider factors and health care insurance coverage
on the likelihood of undergoing revascularization procedures.
Finally, we performed a careful statistical adjustment when
comparing the use of cardiac procedures among groups of
differing smoking status.
Our study also has some limitations. First, the results are lim-
ited to one region and they may not apply to other regions. Sec-
ond, the possibility of biased clinical decision-making prior to
referral for cardiac catheterization cannot be excluded. How-
ever, our focus on revascularization decisions after catheteriza-
tion is nonetheless relevant because, as mentioned earlier, this
is a time at which cardiac surgeons and interventional cardiolo-
gists are asked to accept a patient for treatment (i.e. a process in
which smoking might be held against the patient). Third, our
study is a population-based study that assesses data from a
number of providers in aggregate to determine whether there is
evidence of bias against smokers in clinical decision-making
after cardiac catheterization. Using such an approach, we can
not exclude the possibility that there could be individual pro-
viders (or a small subgroup of providers) who are nonetheless
expressing bias against smokers in their clinical decision-mak-
ing. Our study does not have the statistical power to detect bias
in clinical decisions at the level of individual providers. And
finally, smoking status was ascertained only at the time of car-
diac catheterization for our study. We notably do not have
information on potential changes in smoking status in the fol-
low-up period after catheterization, and it is possible that
changes in smoking status after catheterization could influence
clinical decisions, just as could smoking status at baseline. This
issue of changes in smoking status, and the influence of such
changes on clinical decisions, deserves further study.
These limitations and caveats aside, our study is nonethe-
less informative. Despite potential for discrimination on the
basis of smoking status in revascularization treatment deci-
sions, current and former smokers undergoing cardiac cathe-
terization in Alberta, Canada are as likely as patients who have
never smoked to undergo revascularization procedures.
These results do not preclude the possibility of biased clinical
decision-making prior to referral for cardiac catheterization
or in other geographic regions. They also do not exclude the
possibility that changes in smoking status after catheterization
could influence clinical decisions.
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